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Abstract
Background: During October 2011 several residents and staff members at a long-term care facility (LTCF) for elderly
fell ill with respiratory symptoms. Several of the residents required hospitalization and one died. Non-typeable
Haemophilus influenzae (NTHi) was identified as the causative pathogen.
Methods: A descriptive analysis of the outbreak and countermeasures was performed. For each identified bacterial
isolate implied in the outbreak, standard laboratory resistance testing was performed, as well as molecular typing and
phylogenetic analysis.
Results: The identified H. influenzae was beta-lactamase negative but had strikingly high MIC-values of ampicillin,
cefuroxime and cefotaxime. All isolates displayed the same mutation in the ftsI gene encoding penicillin-binding
protein (PBP) 3, and all but one were identified as sequence type 14 by Multilocus Sequence Typing (MLST). In
total 15 individuals in connection to the LTCF; 8 residents, 6 staff members and one partner to a staff member
were colonized with the strain.
Conclusion: This report illustrates the existence of non-typeable H. influenzae with high virulence, and furthermore
emphasizes the importance of continuous surveillance of possible outbreaks in health care facilities and prompt
measures when outbreaks occur.
Keywords: Ampicillin, Betalactamase negative, BLNAR, Long-term care facility, Haemophilus influenzae, Non-typeable,
Outbreak, Resistant
Background
Haemophilus influenzae is a respiratory tract commensal
that is associated with upper respiratory tract infections,
but also meningitis and septicemia [1]. After the intro-
duction of a H. influenzae type b (Hib) vaccine in the
childhood vaccination program in 1992, non-typeable H.
influenzae (NTHi) have dominated H. influenzae mor-
bidity in Sweden [2], but NTHi are less prone to cause
severe infections than Hib in unvaccinated populations
[3]. Recent studies have reported an increase in invasive
disease caused by NTHi in individuals > 60 years of age
[2] and a recent review has suggested increased surveil-
lance and typing activities of NTHi [4]. Beta-lactam
resistance in H. influenzae is caused either by the pro-
duction of beta-lactamases or by amino acid substitu-
tions in the penicillin binding protein (PBP) 3 resulting
in decreased affinity for penicillins and cephalosporins
[5]. The amino acid substitution pattern can be used to
divide these isolates into three different groups [6].
Outbreaks of infections caused by NTHi in long-term
care facilities (LTCF) for elderly are rare and have only
been reported occasionally [7, 8].* Correspondence: fredrik.resman@med.lu.se
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Outbreak description
On October 5th, 2011, three residents (all aged 80 years
or older) from an LTCF were referred to the hospital of
Karlskrona, Sweden, with fever, cough and respiratory
distress. Due to the suspicion of an outbreak of a commu-
nicable respiratory tract pathogen, the general practitioner
(GP) responsible for the LTCF contacted the County
medical officer for Communicable Disease Control
(CCDC). Patients were tested for influenza virus with poly-
merase chain reaction (PCR) and urinary antigen test for
Legionella pneumophila serogroup 1. Samples from the
nasopharynx, urine and blood were obtained for bacterial
culture. All patients received benzylpenicillin (PcG) intra-
venously according to national guidelines. Due to suspicion
of influenza, oseltamivir was administered to the hospital-
ized as well as the eight non-infected residents at the
LTCF. Both influenza and Legionella tests were negative
and oseltamivir was discontinued two days later.
The LTCF consisted of twelve separate apartments occu-
pied by 11 residents. The staff generally wore protective
clothing and had access to alcohol-based hand sanitizers.
On October 5th, several staff members also had respiratory
symptoms and a few were on sick-leave. Four staff mem-
bers with mild respiratory tract symptoms consulted the
Dept. of Infectious diseases on October 6th, encouraged by
the CCDC, and were in addition to nasopharyngeal cultures
sampled for influenza virus A and B (n = 3), Mycoplasma
pneumoniae (n = 4) and Respiratory Syncytial virus (n = 3).
Two of the hospitalized residents were diagnosed with
pneumonia as confirmed by X-ray, while the third was
considered as a bacterial bronchitis. On October 8th, naso-
pharyngeal cultures from all three hospitalized patients
grew a beta-lactamase negative H. influenzae with positive
screening for Beta-lactam non-susceptibility and resistant
to co-trimoxazole (SXT). The isolates were susceptible to
tetracycline (TET) and ciprofloxacin (CIP). The isolates
were further characterized with MIC testing for ampicillin
(AMP) and cefotaxime (CTX), and sent to the Swedish
Institute for Communicable Disease Control (SMI) for cap-
sular typing. On October 9th, a female resident without ob-
vious symptoms of infection died at the LTCF. The autopsy
showed that the cause of death was an extensive pneumo-
nia, and an isolate obtained from the pulmonary tissue re-
vealed a beta-lactamase negative Hi with an identical
susceptibility pattern as the hospitalized residents. On
October 10th, one more resident from the same LTCF was
admitted to the hospital with pneumonia and was treated
with doxycycline at admission. The nasopharyngeal cul-
ture yielded a Hi isolate with the same antibiogram as the
previously hospitalized patients. A summary of the clinical
information available for the four hospitalized residents is
presented in Table 1.
Several actions were taken by the CCDC three days after
the initiation of the outbreak. Regular meetings were
arranged with all responsible professionals according to
the local epidemic plan. The hygiene routines at the LTCF
were surveyed by the infection control team. It was agreed
that there was an outbreak of an NTHi with an unusual
susceptibility pattern, seemingly high virulence and ability
to spread. No new residents were admitted to the LTCF
until the spread was under control. Education was given




A retrospective chart review was performed for the four
hospitalized patients. Disease severity was evaluated
using the CRB-65-system (confusion-respiratory rate-
blood pressure-age >65 years) [9].
Microbiological methods
Nasopharyngeal swabs (Copan, Brescia, Italy) were ob-
tained from 60 individuals, as part of standard care: 10
residents (6 with/4 without symptoms), 49 staff members
(7 with/42 without symptoms), and one relative to a staff
member presenting with symptoms of upper respiratory
tract infection. An additional sample was obtained from
pulmonary tissue of the resident that died. Nasopharyngeal
swabs were cultured according to standard methodology.
In brief nasopharyngeal swabs were cultured on Blood agar
incubated in anaerobic environment and Hematin agar in-
cubated in 5 % CO2. Olandomycin-discs (50 μg) were used
to improve the detection of H. influenzae. Species identifi-
cation was performed using MALDI-TOF (Microflex and
Biotyper 3.0, Bruker Daltonics, Billerica, MA) with standard
parameters. Susceptibility testing was performed according
to EUCAST.
In October 2011 all H. influenzae isolates isolated at
the Dept. of Clinical Microbiology, Karlskrona were sub-
jected to beta-lactam resistance screening using the PCG
1 unit disc as recommended by EUCAST. Briefly, iso-
lates displaying a zone of PCG ≤ 12 mm were further
analysed with Cefinase disk (Biomerieux, Solna, Sweden)
to detect beta-lactamase production. Beta-lactamase nega-
tive isolates were further tested with Etest (Biomerieux)
on MH-F agar to evaluate the susceptibility to AMP and
CTX. In retrospect 14 isolates in this study were tested
with Etest for susceptibility to cefuroxime (CXM). All
isolates were also tested for susceptibility to TET, SXT,
nalidixic acid (NAL), cefaclor (CKL), and ampicillin/
clavulanic acid (ACL) using disk diffusion on MH-F
agar according to EUCAST methodology (www.eucast.org).
Finally, the total number of nasopharyngeal swabs ana-
lyzed during October 2009–2011 was retrieved from
the Laboratory Information System.
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Table 1 Clinical information of the hospitalized residents evaluated according to the CRB-65 score, plasma lactate and C-reactive protein (CRP) at admission

















1 F 30 302 80 37,4 190/105 2.4 2 Cardiac incompensation,
pleural fluid
5 Asthma
2 M 46 380 87 39,2 87/58 3.1 3 Infective infiltrates in
both lungs
5 Hypothyreosis
3 F 28 269 81 37,4 130/60 2 1 Infective infiltrate in
right lung
4 Asthma, Diabetes mellitus,
Renal failure, Stroke, Vascular
dementia
















Molecular typing and phylogenetic analyses
The ftsI gene was analysed as published by Skaare et al.
[10]. Consensus and protein sequences were generated
using BioEdit 7.0.9.0. The available outbreak isolates as
well as 31 controls (21 invasive Swedish NTHi cases
[11] and 10 randomly selected Swedish nasopharyngeal
isolates were sequence-typed using PCR primers and
conditions according to the H. influenzae protocol
(http://haemophilus.mlst.net/). Sequences were trimmed
manually, concatenated, aligned and edited using ClustalX
[12]. A best-fitting nucleotide substitution model was esti-
mated using jModeltest 0.1.9 [13]. A Maximum likelihood
tree was constructed in MEGA5.05 [14] using the General
Time Reversible model including invariable sites and rate
variation (GTR + I +G). Support for internal branches was
obtained by 1000 bootstrap replicates. The resulting
phylogenetic tree was visualized using FigTree v.1.3.1
(http://tree.bio.ed.ac.uk/software/figtree).
Ethics statement
The study was performed in accordance with approval
by The regional ethic review board in Lund, Sweden
(2014/533).
Results
In total 15 individuals were positive for a beta-lactamase
negative H. influenzae resistant to PCG and STX. Fourteen
of these isolates were from nasopharynx (7 residents, 6
staff members, one partner to a staff member) and one
from lung tissue (post-mortem culture). All isolates were
susceptible to NAL and TET and displayed MIC values for
AMP and CTX near the clinical breakpoints while CXM
MIC was 16 mg/L. The MIC for AMP were 1 or 2 mg/L
(current EUCAST breakpoints S ≤ 2 mg/L, R > 2 mg/L)
and for CTX 0.125 or 0.25 mg/L (S ≤ 0125 mg/L, R >
0.125 mg/L). The reported result for ACL was inferred
from the MIC-value from AMP. Isolates with this particu-
lar susceptibility pattern were not observed in any other
clinical samples in October 2011 in County Blekinge. The
three isolates sent to the Swedish CDC for capsule typing
by PCR were determined as NTHi.
Fourteen of the 15 NTHi isolates with the specific sus-
ceptibility pattern were saved and available for further
analysis. Six isolates were from residents, 7 from staff
members and one from a relative to a staff member. All
isolates displayed the same ftsl-gene sequence with a
corresponding amino acid motif of Asn526Lys (genovar
IIb [14]), and a homogenous MLST-pattern where all
but one outbreak isolate were subtyped to be ST 14.
Interestingly, the isolates clustered with invasive NTHi
isolates from other parts of Sweden (Fig. 1).
In October 2011, 159 nasopharyngeal cultures in total
were analyzed in County Blekinge. The corresponding
figures for 2009 and 2010 were 94 and 113, respectively.
The proportion of H. influenzae during the same 3-year
period (2009–2011) was 7 %, 10 % and 13 %. The resist-
ance to CTX has historically in this area been very low
(single isolates per year) and in samples not related to
the outbreak CTX-resistance was not observed during
the time of the outbreak.
The first three residents admitted to hospital were ad-
ministered PcG. All three experienced an initial clinical im-
provement. The fourth patient received doxycycline from
start. All four patients admitted to the hospital and 9 of the
colonized residents and staff, were treated with doxycycline.
A control culture was obtained approximately three weeks
later. The outbreak strain still colonized the nasopharyngeal
flora in five of these individuals. None of the residents and
staff required hospitalization due to respiratory tract infec-
tions during the weeks after the outbreak.
Discussion
This outbreak demonstrates the potential virulence of
subtypes of non-typeable H. influenzae, and highlights
the important roles of all parts of the healthcare system
to identify and control an outbreak. The outbreak was
suspected by an alert GP, who contacted the CCDC
leading to adequate sampling of the suspected index pa-
tients and quick measures of control. The detection was
further facilitated by the new screening method for de-
tection of beta-lactam resistance in H. influenzae recom-
mended by EUCAST using PcG. The testing of AMP
only had in these strains probably led to false conclu-
sions, since AMP-resistance was not readily detected but
cephalosporin resistance was pronounced. There were
no geographically unrelated clinical isolates displaying
the specific antibiogram identified during October 2011
in County Blekinge supporting the local characteristics
of the outbreak.
A high attack rate was observed as 7 of the 11 residents
were colonized, four of them were hospitalized and a fifth
resident died due to pneumonia. In this patient no other
pathogens than the specific Hi-strain were isolated from
lung tissue. Several of the staff, without underlying disease,
experienced respiratory tract symptoms at the time of the
outbreak and in 6 of these the outbreak strain was iso-
lated. The pathogenicity of NTHi is substantially lower
and different than that of Hib [3], but in this outbreak an
NTHi strain caused severe infections supporting the no-
tion that some lineages of NTHi have a higher virulence.
MLST and ftsI-gene sequencing showed a clonal distribu-
tion of the epidemiologically related isolates, and the main
ST-type was 14. Interestingly, the outbreak isolates clus-
tered with a recently acknowledged lineage of invasive iso-
lates of NTHI with the same ftsI sequence from several
larger regions in Sweden [11]. The ST 14 cluster has also
been demonstrated as the subtype most prone to cause
hospitalization among subtypes of NTHi in a recent
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Norwegian study [15]. In vitro studies have indicated
that NTHi with specific changes in PBP3 may be more
prone to invasion into the host epithelial cells through
micropinocytosis [5], even though this is not likely to
be related to the PBP-3 change per se [16]. It is unlikely
that the isolation of the same H. influenzae in all cases
would be coincidental, and that the outbreak was due
to another microorganism. Haemophilus influenzae is not
a common colonizer of the respiratory tract in healthy
adults such as the staff [17], and a in a recent screening of
98 non-infected residents of a different Swedish LTCF,
no resident was colonized with H. influenzae (own un-
published data).
According to Swedish national guidelines patients
with moderate pneumonia are to be treated with i.v.
PcG 1-3 g × 3 (www.infektion.net). The first three resi-
dents admitted to hospital were administered PcG.
Interestingly, all three experienced an initial clinical im-
provement despite the, from a microbiological point of
view, ineffective therapy. This might be in part due to
the supportive therapy, but CRP-values were also lower
following three days of treatment indicating an effect
on the infection. As bacterial cultures from the lower
respiratory tracts were not obtained, we might have
underestimated the presence of other bacterial patho-
gens (i.e. pneumococci) in these patients. However, a
recent retrospective analysis of invasive H. influenzae
infections suggested that patient empirically treated
with PcG, had a good prognosis if the treatment was
altered according to culture results, while worse out-
comes were seen in patients with a definite treatment
of PcG in comparison to CXM [18]. Thirteen of the 15
residents and staff that were positive for the outbreak
strain were eventually treated with doxycycline. A con-
trol culture was obtained approximately three weeks
later. The outbreak strain still colonized the nasopha-
ryngeal flora in five of these individuals despite ad-
equate doxycycline treatment. No further treatment
was administered, and no further cases were seen after
the actions taken by the CCDC, despite the fact that
some staff and residents were still colonized with the
outbreak strain.
Conclusions
We conclude that a limited outbreak of a beta-lactamase
negative NTHi ST 14 with MIC values for AMP and
Fig. 1 A phylogenetic tree from concatenated MLST sequences of the outbreak isolates (n = 14) as well as of 31 control isolates. The outbreak
isolates are shown in blue text. Isolates from a suggested cluster of BLNAR genotype IIb isolates with identical PBP-3 sequences are shown in red
(n = 7). Randomly selected controls are shown in black, where nasopharyngeal controls are denoted as “nph”, and invasive control are denoted as
“invasive”. The tree shows a clonal clustering of the outbreak isolates, with one isolate separated from the rest. Interestingly, the outbreak isolates
cluster with the suggested BLNAR clone [15]
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CTX just at the clinical breakpoints occurred and was
associated with severe disease. The outbreak may have
been missed if ampicillin only had been used to detect
BLNARs, but these strains were easily detected with
the EUCAST recommended PCG 1U disk screen. The
outbreak strain was closely related to a recently ac-
knowledged lineage of NTHI. The particular NTHi
clone (ST-14) seems to be associated with severe in-
fections and further studies are needed to elucidate
the virulence mechanisms and epidemiology of this
particular clone.
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